Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05063_nanopub.RAqIBHxwcLlP4toeIOk4g4lPR1CX1fq14CljbRW2Q4bjg#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05063 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05063 label "Mitoquinone [drugbank:DB05063]" assertion.
- drugbank:DB05063 seeAlso DB05063 assertion.
- drugbank:DB05063 description "Mitoquinone is based on a novel technology, targeted lipophilic cations, that transport and concentrate antioxidants into the mitochondria -- organelles inside cells that provide energy for life processes -- where they accumulate up to a thousand fold. In 2004, a genomic study of hereditary early-onset Parkinson's disease demonstrated a direct molecular link between mitochondrial dysfunction and the pathogenesis of Parkinson's disease. Mitochondrial dysfunction also has been shown to represent an early critical event in the pathogenesis of the sporadic form of Parkinson's disease. Clinical studies by the Parkinson's Study Group show that very high doses of an antioxidant called Coenzyme Q (which Mitoquinone effectively targets into mitochondria) appear to slow the progression of Parkinson's disease symptoms." assertion.
- drugbank:DB05063 identifier "drugbank:DB05063" assertion.
- drugbank:DB05063 title "Mitoquinone" assertion.
- drugbank:DB05063 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05063 drugbank_vocabulary:drugbank-id "DB05063" assertion.
- drugbank:DB05063 bio2rdf_vocabulary:x-identifiers.org DB05063 assertion.
- drugbank:DB05063 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05063" assertion.
- drugbank:DB05063 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05063 bio2rdf_vocabulary:identifier "DB05063" assertion.